Inflammation and taste disorders: Mechanisms in taste buds

Annals of the New York Academy of Sciences

Volumn 1170, Issue , 2009, Pages 596-603

  Wang, Hong ^a   Zhou, Minliang ^a   Brand, Joseph ^a,b   Huang, Liquan ^a  

^a MONELL CHEMICAL SENSES CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chemosensory disorders; Inflammation; Interferons; Toll like receptors

Indexed keywords

ALPHA INTERFERON; INTERFERON RECEPTOR; PROTEIN C FOS; RECEPTOR ANTIBODY; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7;

APOPTOSIS; BACTERIAL INFECTION; CELL TYPE; CONFERENCE PAPER; CYTOKINE PRODUCTION; DOWN REGULATION; EPITHELIUM; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATION; MOLECULAR DYNAMICS; NEOPLASM; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TASTE BUD; TASTE DISCRIMINATION; TASTE DISORDER; TURNOVER TIME; UPREGULATION; VIRUS INFECTION;

BACTERIA (MICROORGANISMS); MAMMALIA; MUS;

EID: 68649128599     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04480.x     Document Type: Conference Paper

References (34)

1. Heald, A.E. & S.S. Schiffman. 1997. Taste and smell. Neglected senses that contribute to the malnutrition of AIDS. N. C. Med. J. 58: 100-104.
2. Sherry, V.W. 2002. Taste alterations among patients with cancer. Clin. J. Oncol. Nurs. 6: 73-77.
3. Wickham, R.S., M. Rehwaldt, C. Kefer, et al. 1999. Taste changes experienced by patients receiving chemotherapy. Oncol. Nurs. Forum 26: 697- 706.
4. Pribitkin, E., M.D. Rosenthal & B.J. Cowart. 2003. Prevalence and causes of severe taste loss in a chemosensory clinic population. Ann. Otol. Rhinol. Laryngol. 112: 971-978.
5. Henkin, R.I., A.L. Larson & R.D. Powell. 1975. Hypogeusia, dysgeusia, hyposmia, and dysosmia following influenza-like infection. Ann. Otol. Rhinol. Laryngol. 84: 672-682.
6. Goodspeed, R.B., J.F. Gent & F.A. Catalanotto. 1987. Chemosensory dysfunction. Clinical evaluation results from a taste and smell clinic. Postgraduate Med. 81: 251-260.
7. Cullen, M.M. & D.A. Leopold. 1999. Disorders of smell and taste. Med. Clin. North Am. 83: 57-74.
8. Graham, C.S., B.G. Graham, J.A. Bartlett, et al. 1995. Taste and smell losses inHIV infected patients. Physiol. Behav. 58: 287-293.
9. Smith, F.R., R.I. Henkin & R.B. Dell. 1976. Disordered gustatory acuity in liver disease. Gastroenterology 70: 568-571.
10. Weiffenbach, J.M., L.K. Schwartz, J.C. Atkinson, et al. 1995. Taste performance in Sj̈ogren's syndrome. Physiol. Behav. 57: 89-96.
11. Gomez, F.E., L. Cass'Is-Nosthas, J.C. Morales-de- Le'on, et al. 2004. Detection and recognition thresholds to the 4 basic tastes in Mexican patients with primary Sj̈ogren's syndrome. Eur. J. Clin. Nutr. 58: 629-636.
12. Campbell, S.M., A. Montanaro & E.J. Bardana. 1983. Head and neck manifestations of autoimmune disease. Am. J. Otolaryngol. 4: 187-216.
13. Saki'c, B., H. Szechtman, T. Braciak, et al. 1997. Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Res. Bull. 44: 155-165.
14. Kwant, A. & B. Saki'c. 2004. Behavioral effects of infection with interferon-gamma adenovector. Behav. Brain Res. 151: 73-82.
15. Kawai, T. & S. Akira. 2007. TLR signaling. Semin Immunol. 19: 24-32.
16. Brikos,C. & L.A. O'Neill. 2008. Signalling of toll-like receptors. Handb Exp. Pharmacol. 183: 21-50.
17. Kishimoto, T., T. Taga & S. Akira. 1994. Cytokine signal transduction. Cell 76: 253-262.
18. Ihle, J.N. 1995. Cytokine receptor signalling. Nature 377: 591-594.
19. Wang, H., M. Zhou, J. Brand, et al. 2007. Inflammation activates the interferon signaling pathways in taste bud cells. J. Neurosci. 27: 10703-10713.
20. Bogunovic, M., S.H. Dave, J.S. Tilstra, et al. 2007. Enteroendocrine cells express functional Toll-like receptors. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G1770-G1783.
21. Shuto, T., K. Kato, Y. Mori, et al. 2005. Membraneanchored CD14 is required for LPS-induced TLR4 endocytosis in TLR4/MD-2/CD14 overexpressing CHOcells. Biochem. Biophys. Res. Commun. 338: 1402- 1409.
22. Wu, H., H. Wang, W. Xiong, et al. 2008. Expression patterns and functions of toll-like receptors in mouse sertoli cells. Endocrinology 149: 4402-4412.
23. Triantafilou, M., F.G. Gamper, R.M. Haston, et al. 2006. Membrane sorting of toll-like receptor (TLR)- 2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J. Biol. Chem. 281: 31002- 31011.
24. Huang, L., Y.G. Shanker, J. Dubauskaite, et al. 1999. Ggamma13 colocalizes with gustducin in taste receptor cells and mediates IP3 responses to bitter denatonium. Nat. Neurosci. 2: 1055-1062.
25. Uehara, A., Y. Fujimoto, K. Fukase, et al. 2007. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol. Immunol. 44: 3100-3111.
26. Larsen, P.H., T.H. Holm & T.Owens. 2007. Toll-like receptors in brain development and homeostasis. Sci. STKE 2007: pe47.
27. Kalvakolanu, D.V. 2003. Alternate interferon signaling pathways. Pharmacology & Therapeutics 100: 1-29.
28. Theofilopoulos, A.N., R. Baccala, B. Beutler, et al. 2005. Type I interferons in immunity and autoimmunity. Annu. Rev. Immunol. 23: 307-335.
29. Kellokumpu-Lehtinen, P., E. Nordman & A. Toivanen. 1989. Combined interferon and vinblastine treatment of advanced melanoma: evaluation of the treatment results and the effects of the treatment on immunological functions. Cancer Immunol. Immunother. 28: 213-217.
30. Jones, G.J. & L.M. Itri. 1986. Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients. Cancer 57: 1709-1715.
31. Abdollahi,M. & M. Radfar. 2003. A review of druginduced oral reactions. J. Contemp. Dent. Pract. 4: 10-31.
32. Tanaka, N., M. Ishihara, M. Kitagawa, et al. 1994. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77: 829-839.
33. Nicholson, D.W., A. Ali, N.A. Thornberry, et al. 1995. Identification and inhibition of the ICE/CED- 3 protease necessary formammalian apoptosis. Nature 376: 37-43.
34. Garnier, P.,W.Ying & R.A. Swanson. 2003. Ischemic preconditioning by caspase cleavage of poly(ADPribose) polymerase-1. J. Neurosci. 23: 7967-7973.